Structure-Activity Studies on Antiproliferative Factor (APF) Glycooctapeptide Derivatives

Area of Science:

• Biochemistry
• Cell Biology
• Urology

Background:

• Antiproliferative factor (APF) is a glycopeptide linked to interstitial cystitis/painful bladder syndrome (IC/PBS).
• Previous studies showed that unsialylated APF (as-APF) and its truncated form (as-APF8) inhibit bladder epithelial cell proliferation.
• Understanding the structure-activity relationship of as-APF is crucial for developing therapeutic strategies.

Purpose of the Study:

• To investigate the structural basis for the sustained antiproliferative activity of the truncated eight amino acid as-APF (as-APF8).
• To synthesize and evaluate amino acid-substituted derivatives of as-APF8 for their ability to inhibit bladder epithelial cell proliferation.
• To determine the solution conformations of these derivatives using biophysical techniques.

Main Methods:

• Synthesis of as-APF8 derivatives with specific amino acid substitutions.
• In vitro assays to measure the inhibition of bladder epithelial cell proliferation.
• Circular Dichroism (CD) and Nuclear Magnetic Resonance (NMR) spectroscopy to analyze solution conformations.

Main Results:

• Single amino acid substitutions in as-APF8 generally reduced antiproliferative activity.
• Replacing the trivaline tail with three alanines (derivative 9) fully maintained antiproliferative potency.
• Derivative 9 represents the simplest, fully potent APF analogue synthesized to date.

Conclusions:

• The trivaline tail of as-APF8 is not essential for maintaining antiproliferative activity.
• Derivative 9, a simplified analogue, is a promising candidate for further investigation in IC/PBS.
• Structural modifications can yield potent APF analogues with potential therapeutic applications.